A Hyperoxic Lung Injury Model in Premature Rabbits: The Influence of Different Gestational Ages and Oxygen Concentrations
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
MANZANO, Roberta Munhoz
MASCARETTI, Renata Suman
CARRER, Valeria
HADDAD, Luciana Branco
FERNANDES, Aline Rabelo
REYES, Ana M. A.
Citação
PLOS ONE, v.9, n.4, article ID e95844, 8p, 2014
Resumo
Background: Many animal models have been developed to study bronchopulmonary dysplasia (BPD). The preterm rabbit is a low-cost, easy-to-handle model, but it has a high mortality rate in response to the high oxygen concentrations used to induce lung injury. The aim of this study was to compare the mortality rates of two models of hyperoxia-induced lung injury in preterm rabbits. Methods: Pregnant New Zealand white rabbits were subjected to caesarean section on gestational day 28 or 29 (full term = 31 days). The premature rabbits in the 28-day gestation group were exposed to room air or FiO(2) >= 95%, and the rabbits in the 29-day gestation group were exposed to room air or FiO(2) = 80% for 11 days. The mean linear intercept (Lm), internal surface area ( ISA), number of alveoli, septal thickness and proportion of elastic and collagen fibers were quantified. Results: The survival rates in the 29-day groups were improved compared with the 28-day groups. Hyperoxia impaired the normal development of the lung, as demonstrated by an increase in the Lm, the septal thickness and the proportion of elastic fibers. Hyperoxia also decreased the ISA, the number of alveoli and the proportion of collagen fibers in the 28-day oxygen-exposed group compared with the control 28-day group. A reduced number of alveoli was found in the 29-day oxygen exposed animals compared with the control 29-day group. Conclusions: The 29-day preterm rabbits had a reduced mortality rate compared with the 28-day preterm rabbits and maintained a reduction in the alveoli number, which is comparable to BPD in humans.
Palavras-chave
Referências
- Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945
- Albertine KH, 2013, SEMIN PERINATOL, V37, P60, DOI 10.1053/j.semperi.2013.01.001
- Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6
- Bland RD, 2005, AM J RESP CRIT CARE, V172, P899, DOI 10.1164/rccm.200503-3840C
- Bland RD, 2003, BIOL NEONATE, V84, P101, DOI 10.1159/000071012
- Bland RD, 2003, AM J PHYSIOL-LUNG C, V285, pL76, DOI 10.1152/ajplung.00395.2002
- BONIKOS DS, 1975, LAB INVEST, V32, P619
- Bremer F, 2012, PLOS ONE, V7
- Chang M, 2013, AM J TRANSL RES, V5, P594
- Chen YW, 1997, J PEDIATR, V130, P409, DOI 10.1016/S0022-3476(97)70202-6
- Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003
- Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8
- COALSON JJ, 1995, AM J RESP CRIT CARE, V152, P640
- Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333
- Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004
- COALSON JJ, 1992, AM REV RESPIR DIS, V145, P872
- COALSON JJ, 1982, EXP MOL PATHOL, V37, P335, DOI 10.1016/0014-4800(82)90046-6
- CRAPO JD, 1980, AM REV RESPIR DIS, V122, P123
- Deakins KM, 2009, RESP CARE, V54, P1252
- DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320
- FRANK L, 1991, PEDIATR RES, V29, P292, DOI 10.1203/00006450-199103000-00014
- Guen GLC, 2008, EUR RESP J UK, V32, P1520
- Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC
- Johnson BH, 2009, PEDIATR RES, V66, P260, DOI 10.1203/PDR.0b013e3181b1bcd2
- Karnak I, 1999, RES EXP MED, V198, P277, DOI 10.1007/s004330050111
- KIKKAWA Y, 1971, AM J PATHOL, V64, P423
- Kovar J, 2002, J APPL PHYSIOL, V93, P629, DOI 10.1152/japplphysiol.01044.2001
- LUM H, 1987, J APPL PHYSIOL, V62, P1865
- MacRitchie AN, 2001, AM J PHYSIOL-LUNG C, V281, pL1011
- MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391
- Mascaretti RS, 2009, CLINICS, V64, P1099, DOI 10.1590/S1807-59322009001100010
- Mataloun Marta M G B, 2006, J Pediatr (Rio J), V82, P179, DOI 10.1590/S0021-75572006000300005
- Mataloun MMGB, 2009, BRAZ J MED BIOL RES, V42, P606, DOI 10.1590/S0100-879X2009000700004
- Moore S, 2011, JCCC HONORS J, V11
- NILSSON R, 1982, ACTA ANAESTH SCAND, V26, P89
- Okamoto C. T., 2009, Jornal Brasileiro de Patologia e Medicina Laboratorial, V45, P155, DOI 10.1590/S1676-24442009000200011
- Parker Thomas A, 2003, Semin Neonatol, V8, P51, DOI 10.1016/S1084-2756(02)00191-4
- Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452
- RANDELL SH, 1990, AM J PATHOL, V136, P1259
- Saugstad OD, 2010, J PERINAT MED, V38, P571, DOI 10.1515/JPM.2010.108
- Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004
- Speer Christian P, 2003, Semin Neonatol, V8, P29, DOI 10.1016/S1084-2756(02)00190-2
- Thibeault DW, 2003, PEDIATRICS, V111, P766, DOI 10.1542/peds.111.4.766
- Thomson MA, 2004, AM J RESP CRIT CARE, V169, P1054, DOI 10.1164/rccm.200309-1276OC
- THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P765
- Walsh MC, 2006, PEDIATRICS, V118, P1328
- Warner BB, 1998, AM J PHYSIOL, V275, P110
- Weinberger B, 2002, TOXICOL APPL PHARM, V181, P60, DOI 10.1006/taap.2002.9387
- Lim K, 2014, J PEDIATR-US, V164, P730, DOI 10.1016/j.jpeds.2013.11.072